0.3102

8.76% -0.0298

After Hours: .31 -0.0002 -0.06%

VolitionRX Ltd (VNRX)

Overview News Price History Option Chain Discussions Forecast

VolitionRX Ltd stock is traded at $0.3102, with a volume of 1.04M. It is down -8.76% in the last 24 hours and down -56.63% over the past month. VolitionRX Limited, a life sciences company, engages in the development of blood tests to help diagnose a range of cancers worldwide. The company develops 39 epigenetic Nu.Q blood assays based on its Nucleosomics biomarker discovery platform. VolitionRX Limited is based in Singapore.

Previous Close:

$0.34

Open:

$0.3371

24h Volume:

1.04M

Relative Volume:

0.15

Market Cap:

$5.86M

Revenue:

$2.47M

Net Income/Loss:

$-24.73M

P/E Ratio:

-0.0736

EPS:

-4.213

Net Cash Flow:

$-20.36M

1W Performance:

-11.27%

1M Performance:

-56.63%

6M Performance:

-92.35%

1Y Performance:

-97.53%

1-Day Range:

$0.3058

$0.3401

1-Week Range:

$0.3058

$0.3609

52-Week Range:

$0.3058

$14.80

VolitionRX Ltd Stock (VNRX) Company Profile

Name

VolitionRX Ltd

Sector

Healthcare (1069)

Industry

Diagnostics & Research (49)

Phone

646 650 1351

Address

No. 24-05 Shaw Centre, 1 Scotts Road, Singapore, TX

Employee

Twitter

@VolitionRx

Next Earnings Date

2026-08-13

Latest SEC Filings

VNRX's Discussions on Twitter

Compare VNRX vs TMO, DHR, NTRA, IQV, A

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
VNRX VolitionRX Ltd	0.3102	6.43M	2.47M	-24.73M	-20.36M	-4.213
TMO Thermo Fisher Scientific Inc	609.82	223.02B	45.20B	6.87B	6.75B	18.19
DHR Danaher Corp	200.14	140.97B	24.78B	3.68B	5.29B	5.1743
NTRA Natera Inc	328.93	47.01B	2.50B	-226.32M	71.51M	-1.6412
IQV Iqvia Holdings Inc	261.77	42.35B	16.63B	1.39B	2.12B	8.0674
A Agilent Technologies Inc	146.93	40.35B	7.23B	1.41B	1.09B	4.979

VolitionRX Ltd Stock (VNRX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-08-25	Initiated	H.C. Wainwright	Buy
Feb-01-23	Downgrade	The Benchmark Company	Buy → Hold
Feb-17-22	Resumed	Cantor Fitzgerald	Overweight
Mar-10-21	Initiated	Cantor Fitzgerald	Overweight
May-16-18	Initiated	Maxim Group	Buy
May-14-18	Reiterated	The Benchmark Company	Buy
Sep-07-16	Reiterated	Rodman & Renshaw	Buy
Feb-01-16	Initiated	Rodman & Renshaw	Buy

View All

VolitionRX Ltd Stock (VNRX) Latest News

06:05 AM

VOLITIONRX LTD SEC Filing (Sep 11, 2026) - Stock Titan

06:05 AM

Sep 10, 2026

Lagoda Investment Management, L.P. Adds VolitionRX Ltd (VNRX) -- Shares Look 98% Undervalued on GF Value - GuruFocus

Sep 10, 2026

VNRX Looks 98.1% Undervalued on GF Value™ Despite Financial Dist - GuruFocus

Sep 10, 2026

A blood-based method detected 95% of stage I and II cancers. - Stock Titan

Sep 10, 2026

Sep 09, 2026

Dilution risk flagged as VolitionRx (NYSE: VNRX) registers more Lind shares for resale - Stock Titan

Sep 09, 2026

Sep 08, 2026

VolitionRx (NYSE: VNRX) details Lind note and warrant stake under 4.99% cap - Stock Titan

Sep 08, 2026

Lagoda Investment Management Elevates VOLITIONRX LTD (AMEX: VNRX) Stake to Activist 13D Filing at 7.4% - Kalkine Media

Sep 08, 2026

Penny Stock VolitionRx Expands Addressable Markets With Key Diagnostic Validations - Benzinga

Aug 27, 2026

$VolitionRX (VNRX.US)$ - Moomoo

Aug 27, 2026

Aug 26, 2026

VolitionRx revenue rises 112% in H1FY26; shares surge 100% - scanx.trade

Aug 26, 2026

Aug 17, 2026